1dd1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1dd1" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dd1, resolution 2.62&Aring;" /> '''CRYSTAL STRUCTURE A...)
Line 1: Line 1:
-
[[Image:1dd1.gif|left|200px]]<br />
+
[[Image:1dd1.gif|left|200px]]<br /><applet load="1dd1" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1dd1" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1dd1, resolution 2.62&Aring;" />
caption="1dd1, resolution 2.62&Aring;" />
'''CRYSTAL STRUCTURE ANALYSIS OF THE SMAD4 ACTIVE FRAGMENT'''<br />
'''CRYSTAL STRUCTURE ANALYSIS OF THE SMAD4 ACTIVE FRAGMENT'''<br />
==Overview==
==Overview==
-
BACKGROUND: Smad4 functions as a common mediator of transforming growth, factor beta (TGF-beta) signaling by forming complexes with the, phosphorylated state of pathway-restricted SMAD proteins that act in, specific signaling pathways to activate transcription. SMAD proteins, comprise two domains, the MH1 and MH2 domain, separated by a linker, region. The transcriptional activity and synergistic effect of Smad4, require a stretch of proline-rich sequence, the SMAD-activation domain, (SAD), located N-terminal of the MH2 domain. To understand how the SAD, contributes to Smad4 function, the crystal structure of a fragment, including the SAD and MH2 domain (S4AF) was determined. RESULTS: The, structure of the S4AF trimer reveals novel features important for Smad4, function. A Smad4-specific sequence insertion within the MH2 domain, interacts with the C-terminal tail to form a structural extension from the, core. This extension (the TOWER) contains a solvent-accessible, glutamine-rich helix. The SAD reinforces the TOWER and the structural core, through interactions; two residues involved in these interactions are, targets of tumorigenic mutation. The solvent-accessible proline residues, of the SAD are located on the same face as the glutamine-rich helix of the, TOWER, forming a potential transcription activation surface. A tandem, sulfate-ion-binding site was identified within the subunit interface, which may interact with the phosphorylated C-terminal sequence of, pathway-restricted SMAD proteins. CONCLUSIONS: The structure suggests that, the SAD provides transcriptional capability by reinforcing the structural, core and coordinating with the TOWER to present the proline-rich and, glutamine-rich surfaces for interaction with transcription partners. The, sulfate-ion-binding sites are potential 'receptors' for the phosphorylated, sequence of pathway-restricted SMAD proteins in forming a heteromeric, complex. The structure thus provides a new model that can be tested using, biochemical and cellular approaches.
+
BACKGROUND: Smad4 functions as a common mediator of transforming growth factor beta (TGF-beta) signaling by forming complexes with the phosphorylated state of pathway-restricted SMAD proteins that act in specific signaling pathways to activate transcription. SMAD proteins comprise two domains, the MH1 and MH2 domain, separated by a linker region. The transcriptional activity and synergistic effect of Smad4 require a stretch of proline-rich sequence, the SMAD-activation domain (SAD), located N-terminal of the MH2 domain. To understand how the SAD contributes to Smad4 function, the crystal structure of a fragment including the SAD and MH2 domain (S4AF) was determined. RESULTS: The structure of the S4AF trimer reveals novel features important for Smad4 function. A Smad4-specific sequence insertion within the MH2 domain interacts with the C-terminal tail to form a structural extension from the core. This extension (the TOWER) contains a solvent-accessible glutamine-rich helix. The SAD reinforces the TOWER and the structural core through interactions; two residues involved in these interactions are targets of tumorigenic mutation. The solvent-accessible proline residues of the SAD are located on the same face as the glutamine-rich helix of the TOWER, forming a potential transcription activation surface. A tandem sulfate-ion-binding site was identified within the subunit interface, which may interact with the phosphorylated C-terminal sequence of pathway-restricted SMAD proteins. CONCLUSIONS: The structure suggests that the SAD provides transcriptional capability by reinforcing the structural core and coordinating with the TOWER to present the proline-rich and glutamine-rich surfaces for interaction with transcription partners. The sulfate-ion-binding sites are potential 'receptors' for the phosphorylated sequence of pathway-restricted SMAD proteins in forming a heteromeric complex. The structure thus provides a new model that can be tested using biochemical and cellular approaches.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1DD1 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DD1 OCA].
+
1DD1 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DD1 OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Lam, S.W.]]
+
[[Category: Lam, S W.]]
[[Category: Lin, K.]]
[[Category: Lin, K.]]
-
[[Category: Qin, B.Y.]]
+
[[Category: Qin, B Y.]]
[[Category: SO4]]
[[Category: SO4]]
[[Category: b-sheet sandwich helix-turn-helix]]
[[Category: b-sheet sandwich helix-turn-helix]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 16:31:06 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:15:22 2008''

Revision as of 10:15, 21 February 2008


1dd1, resolution 2.62Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE ANALYSIS OF THE SMAD4 ACTIVE FRAGMENT

Contents

Overview

BACKGROUND: Smad4 functions as a common mediator of transforming growth factor beta (TGF-beta) signaling by forming complexes with the phosphorylated state of pathway-restricted SMAD proteins that act in specific signaling pathways to activate transcription. SMAD proteins comprise two domains, the MH1 and MH2 domain, separated by a linker region. The transcriptional activity and synergistic effect of Smad4 require a stretch of proline-rich sequence, the SMAD-activation domain (SAD), located N-terminal of the MH2 domain. To understand how the SAD contributes to Smad4 function, the crystal structure of a fragment including the SAD and MH2 domain (S4AF) was determined. RESULTS: The structure of the S4AF trimer reveals novel features important for Smad4 function. A Smad4-specific sequence insertion within the MH2 domain interacts with the C-terminal tail to form a structural extension from the core. This extension (the TOWER) contains a solvent-accessible glutamine-rich helix. The SAD reinforces the TOWER and the structural core through interactions; two residues involved in these interactions are targets of tumorigenic mutation. The solvent-accessible proline residues of the SAD are located on the same face as the glutamine-rich helix of the TOWER, forming a potential transcription activation surface. A tandem sulfate-ion-binding site was identified within the subunit interface, which may interact with the phosphorylated C-terminal sequence of pathway-restricted SMAD proteins. CONCLUSIONS: The structure suggests that the SAD provides transcriptional capability by reinforcing the structural core and coordinating with the TOWER to present the proline-rich and glutamine-rich surfaces for interaction with transcription partners. The sulfate-ion-binding sites are potential 'receptors' for the phosphorylated sequence of pathway-restricted SMAD proteins in forming a heteromeric complex. The structure thus provides a new model that can be tested using biochemical and cellular approaches.

Disease

Known diseases associated with this structure: Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome OMIM:[600993], Pancreatic cancer OMIM:[600993], Polyposis, juvenile intestinal OMIM:[600993]

About this Structure

1DD1 is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Crystal structure of a transcriptionally active Smad4 fragment., Qin B, Lam SS, Lin K, Structure. 1999 Dec 15;7(12):1493-503. PMID:10647180

Page seeded by OCA on Thu Feb 21 12:15:22 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools